Onyx Biotec Ltd. (OBL), a pharmaceutical company specializing in sterile water for injections, is making its debut on the ...

Q3 2024 sales revenue increased 164% year-over-year to $135 thousand.Sequential (quarter-over-quarter) net product revenue growth of 8.3%.Gross profit increased from ($20 thousand) to $24 thousand. WA ...

Telangana's Genome Valley is attracting substantial investments in life sciences. Over Rs. 36,000 crore was invested in the ...

Batch management plays a crucial role in the life sciences industry, ensuring quality, compliance, and traceability. Learn ...

Eli Lilly (NYSE: LLY) sells a broad range of pharmaceuticals treating various diseases, but one portfolio in particular has ...

CRISPR Therapeutics ( CRSP -5.91%) made a name for itself by pioneering advanced gene therapies made with technologies that didn't exist a generation ago. Now, its challenge is to build on its prior ...

YORVIPATH launching in U.S. with product availability expected mid-January 2025; ex-U.S. YORVIPATH revenue of €8.5 million in Q3 - TransCon CNP NDA submission for achondroplasia planned for Q1 2025 ...

The new facility is expected to create more than 800 jobs over the next five years, with 291 jobs coming within the initial ...

HYDERABAD: IT and Industries Minister D Sridhar Babu on Thursday announced that the Congress government has secured ...

Jan was tasked to review regulatory purview of nutraceuticals on account of overlapping issues of nutraceuticals with drugs. It gave report to govt this month.

Continuing its resilience in robust growth, diversified conglomerate Sunshine Holdings PLC posted consolidated revenue of Rs. 30.1 billion for the six months ending 30 September 2024 (1HFY25), an ...